Pharmacokinetics of prednisolone in normal and asthmatic subjects in relation to dose. 1981

W A McAllister, and C R Winfield, and J V Collins

The pharmacokinetics of prednisolone have been studied in asthmatic patients following intravenous injection at three different doses and in normal volunteers at five oral doses. Plasma prednisolone concentrations were measured by radioimmunoassay. With increasing dose there is an increase in the apparent volume of distribution, plasma clearance and half life. The relationship between area under the plasma concentration time curve, maximum concentration and dose is linear but the regression lines do not pass through the origin. These findings following oral and intravenous administration confirm that prednisolone shows non-linear kinetics.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas

Related Publications

W A McAllister, and C R Winfield, and J V Collins
March 1981, British journal of clinical pharmacology,
W A McAllister, and C R Winfield, and J V Collins
June 1979, The Journal of pediatrics,
W A McAllister, and C R Winfield, and J V Collins
January 1986, European journal of clinical pharmacology,
W A McAllister, and C R Winfield, and J V Collins
January 1980, British journal of diseases of the chest,
W A McAllister, and C R Winfield, and J V Collins
October 2016, Drug testing and analysis,
W A McAllister, and C R Winfield, and J V Collins
October 1986, Journal of pharmacokinetics and biopharmaceutics,
W A McAllister, and C R Winfield, and J V Collins
June 1983, British journal of clinical pharmacology,
W A McAllister, and C R Winfield, and J V Collins
July 1984, The American review of respiratory disease,
W A McAllister, and C R Winfield, and J V Collins
November 1977, European journal of clinical pharmacology,
W A McAllister, and C R Winfield, and J V Collins
July 1982, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!